How Does Ibogaine Work?
"In an honest moment, an opioid-peddling CEO may describe iboga as a rabble-rouser threatening to blast a hole in share prices." ("Iboga: The Root of All Healing," by Daniel Brett)
The long-term consequence of addiction is that, when exposed to repeated artificial surges, the brain adapts and rewires. Through the ongoing depletion of natural dopamine levels, according to studies, the “brain adaptations often lead to the person becoming less and less able to derive pleasure from other things they once enjoyed, like food, sex, or social activities;” a state known in psychiatry as “anhedonia,” or the inability of a person to experience pleasure in formerly pleasurable acts.
“Ibogaine cannot open a door by itself, but it is the oil for the hinges.” (Naranjo, 1969, 224)
Here at Ibogaine Treatment UK (a subsidiary of Tabula Rasa Retreat TM), we know full well the importance of post-treatment integration, which is why our facilities are fully geared to aftercare with a team of dedicated, fully trained therapists, nutritionists and medical staff. For the duration of your stay with us, for a recommended two weeks, you will benefit from being a part of a vibrant community with close contact to nature and an atmosphere conducive to healing.
After 12 to 24 hours, depending on the person and ibogaine dose given, addicts will gradually begin to experience less of the hallucinogenic state. Patients can once again return to the “real world” rather than meandering through the halls of memories and recollections (Lotsof; Wachtel). Although there is some variability in the results of such studies, it has been proven that as little as a single ibogaine treatment can halt cravings for up to six months. A series of up to four treatments could help an addict remain clean and craving-free for three or more years. (Nielsen, 2018).
Ibogaine is most known for its helpful effects related to Opiate withdrawal. Several studies conducted have shown ibogaine does not appear to cause addiction and is, in fact, safe. In one study, rodents were given Ibogaine for six consecutive days and researchers examined its effects. They detected no withdrawal symptoms or signs that the rodents experienced cravings at the end of the trial. Even though ibogaine is still classified as a Schedule I drug, suggesting it has the potential for abuse, the National Institute on Drug Abuse does not consider it a danger for abuse or addiction (Nielsen, 2018).
Other addictions to certain substances have seemed to respond well to ibogaine, including cocaine, nicotine, morphine, and alcohol. However, a significant amount of research in this area has been mostly conducted on animals and, to a smaller extent, humans. These studies revealed that addicted rodents, when treated with ibogaine, experienced fewer withdrawal symptoms and a decreased pursuit and intake of the addictive substances (Santos, et al, 2017).